BamSEC and AlphaSense Join Forces
Learn More

Xenon Pharmaceuticals Inc.

NASDAQ: XENE    
Share price (1/8/25): $39.55    
Market cap (1/8/25): $3.015 billion
Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1.1
from 8-K 55 pages 8,461,542 Shares 769,230 Pre-Funded Warrants Xenon Pharmaceuticals Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 43 pages 7,868,854 Shares 327,868 Pre-Funded Warrants Xenon Pharmaceuticals Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 5 pages Amendment No. 1 to the At-The-Market Equity Offering Sales Agreement
12/34/56
EX-1.1
from 8-K 50 pages 8,474,577 Shares 1,694,915 Pre-Funded Warrants Xenon Pharmaceuticals Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 47 pages 4,324,325 Shares Xenon Pharmaceuticals Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 32 pages Xenon Pharmaceuticals Inc. Common Shares At-The-Market Equity Offering Sales Agreement
12/34/56
EX-1
from SC 13G/A 1 page Joint Filing Agreement
12/34/56
EX-1.1
from 8-K 50 pages 3,750,000 Shares Xenon Pharmaceuticals Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 31 pages Xenon Pharmaceuticals Inc. Common Shares At-The-Market Equity Offering Sales Agreement
12/34/56
EX-1.1
from 8-K 48 pages 4,500,000 Shares Xenon Pharmaceuticals Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 32 pages Xenon Pharmaceuticals Inc. Common Shares At-The-Market Equity Offering Sales Agreement
12/34/56
EX-1.1
from 8-K 32 pages Xenon Pharmaceuticals Inc. Common Shares At-The-Market Equity Offering Sales Agreement
12/34/56
EX-1.1
from 8-K 53 pages 4,000,000 Shares Xenon Pharmaceuticals Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 46 pages [—] Shares Xenon Pharmaceuticals Inc. Underwriting Agreement
12/34/56